The clinical course and prognostic factors of severe COVID-19 in Wuhan, China A retrospective case-control study

被引:12
|
作者
Liu, Jiacheng [1 ,2 ]
Tu, Chao [3 ]
Zhu, Muxin [4 ]
Wang, Jianwen [4 ]
Yang, Chongtu [1 ,2 ]
Liu, Wei [4 ]
Xiong, Bin [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan 430022, Hubei, Peoples R China
[2] Wuhan Jinyintan Hosp, Hubei Prov Key Lab Mol Imaging, Wuhan, Hubei, Peoples R China
[3] Wuhan Jinyintan Hosp, Dept Crit Care Med, Wuhan, Hubei, Peoples R China
[4] Wuhan Jinyintan Hosp, TB & Resp Dept, Wuhan, Peoples R China
关键词
biomarkers; classification; coronavirus disease 2019; prognosis; survival; RESPIRATORY-DISTRESS-SYNDROME; CORONAVIRUS DISEASE 2019; EPIDEMIOLOGY; PNEUMONIA; ACE2;
D O I
10.1097/MD.0000000000023996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With the surge of newly diagnosed and severe cases of coronavirus disease 2019 (COVID-19), the death toll is mounting, this study is aimed to explore the prognostic factors of severe COVID-19. This retrospective study included 122 inpatients diagnosed with COVID-19 from January 13 to February 25, 2020. Univariate and multivariate analysis were used to identity the risk factors, receiver operating characteristics curve (ROC) analysis was used for risk stratification. The baseline neutrophil-to-lymphocyte ratio (NLR) (OR = 1.171, 95%CI = 1.049-1.306, P = .005) and Lactate dehydrogenase (LDH) (OR = 1.007, 95%CI = 1.002-1.011, P = .004) were identified as the independent risk factors for severe COVID-19 conditions, and the NLR-LDH grading system was developed to perform risk stratification. The baseline C-reactive protein (CRP) (OR = 1.019, 95%CI = 1.004-1.306, P = .016) and B-type natriuretic peptide (BNP) (OR = 1.018, 95%CI = 1.004-1.035, P = .007) were identified as the independent predictors for disease progression of severe patients. Accordingly, The NLR-LDH grading system was a useful prognostic tool for the early detection of severe COVID-19. And in the severe patients, CRP and BNP seemed to be helpful for predicting the disease progression or death.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Clinical course and outcomes of COVID-19 patients with a history of cerebrovascular disease: a retrospective study in Wuhan
    Bai, Yang
    Liang, Yong
    Wang, Fang
    Chen, Ligang
    Zhao, Yulong
    Zhao, Shoujie
    Zhu, Yejing
    Dong, Yushu
    Liang, Guobiao
    Chen, Dongfeng
    Liu, Lei
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [22] Tocilizumab in severe COVID-19 pneumonia: A retrospective case-control study from eastern India
    Mouli, Tatikonda Chandra
    Patnaik, Rohit Kumar
    Mishra, Shakti Bedanta
    INDIAN JOURNAL OF ANAESTHESIA, 2023, 67 (07) : 647 - 650
  • [23] Prognostic value of baseline clinical and HRCT findings in 101 patients with severe COVID-19 in Wuhan, China
    Yukun Cao
    Xiaoyu Han
    Jin Gu
    Yumin Li
    Jia Liu
    Osamah Alwalid
    Yue Cui
    Xin Zhang
    Chuansheng Zheng
    Yanqing Fan
    Hanping Wu
    Heshui Shi
    Scientific Reports, 10
  • [24] Prognostic value of baseline clinical and HRCT findings in 101 patients with severe COVID-19 in Wuhan, China
    Cao, Yukun
    Han, Xiaoyu
    Gu, Jin
    Li, Yumin
    Liu, Jia
    Alwalid, Osamah
    Cui, Yue
    Zhang, Xin
    Zheng, Chuansheng
    Fan, Yanqing
    Wu, Hanping
    Shi, Heshui
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [25] Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series
    Tao Yao
    Yan Gao
    Qin Cui
    Bo Peng
    Yan Chen
    Jiansheng Li
    Chao Huang
    Chunping He
    Jie Pu
    Jiajun Wei
    Yanqiang Zhan
    Jie Yan
    Jinghua Tian
    Zhaohui Zhang
    Zhichao Liu
    BMC Infectious Diseases, 20
  • [26] Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series
    Yao, Tao
    Gao, Yan
    Cui, Qin
    Peng, Bo
    Chen, Yan
    Li, Jiansheng
    Huang, Chao
    He, Chunping
    Pu, Jie
    Wei, Jiajun
    Zhan, Yanqiang
    Yan, Jie
    Tian, Jinghua
    Zhang, Zhaohui
    Liu, Zhichao
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [27] Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study
    Sun, Haiying
    Ning, Ruoqi
    Tao, Yu
    Yu, Chong
    Deng, Xiaoyan
    Zhao, Caili
    Meng, Silu
    Tang, Fangxu
    Xu, Dong
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (06) : E19 - E23
  • [28] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (vol 395, pg 1054, 2020)
    Zhou, F.
    Yu, T.
    Du, R.
    LANCET, 2020, 395 (10229): : 1038 - 1038
  • [29] Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study
    Uranga, A.
    Villanueva, A.
    Lafuente, I
    Gonzalez, N.
    Legarreta, M. J.
    Aguirre, U.
    Espana, P. P.
    Quintana, J. M.
    Garcia-Gutierrez, S.
    REVISTA CLINICA ESPANOLA, 2022, 222 (01): : 22 - 30
  • [30] Case-control study on risk factors for in-hospital mortality in patients with severe COVID-19
    Wu, Kemei
    Yin, Lili
    Han, Jiangqin
    Cai, Qiuhan
    Guo, Yang
    Jin, Xin
    Wu, Jinling
    Cheng, Yupei
    FRONTIERS IN PUBLIC HEALTH, 2024, 12